The prospective observational study to evaluate a swallowing function and the efficacy of macrolide antibiotics combination therapy in patients with community-acquired pneumonia

The prospective observational study to evaluate a swallowing function and the efficacy of macrolide antibiotics combination therapy in patients with community-acquired pneumonia - Study of swallowing functions and macrolides combination therapy in community acquired therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013446

Enrollment

300

Registered

2014-03-19

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with community-acquired pneumonia(CAP), the definition; 1)infiltrates consistent with CAP seen on a chest radiography, 2)clinical features consistent with CAP, 3)a strong possibility of the affection outside a hospital or long-term care facility.

Exclusion criteria

Exclusion criteria: 1)patients having difficulty in agreement due to consciousness disturbance with no key person, 2)patients with interstitial pneumonia or nontuberculous mycobacterial infections or fungal infections or pulmonary embolism or pneumothorax or pyothorax or severe heart failure 3)hospital-acquired pneumonia(pneumonia that occurs 48 hours or more after hospital admission and that was not present at the time of admission.)

Design outcomes

Primary

Measure	Time frame
30-day and 90-day mortality rates after the admission	—

Countries

Japan

Contacts

Public ContactHiroaki Oka

Tenshindo Hetsugi Hospital Clinical Research Center of Respiratory Medicine

m10d9007@oita-u.ac.jp097-597-5777

Outcome results